LENZ Therapeutics, Inc.

By person

16 insiders · 74 transactions

0.9×

Evert Schimmelpennink holds only 0.9 times base salary in stock. $662.37K of shares against $690.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Evert Schimmelpennink last reported holding, valued at $8.57, the price Common Stock was last bought or sold at on the open market here, on 27 Mar 2026.

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Versant Venture Capital VI, L.P. entity

10% owner

$3.06M (1)

$66.60M (34)

−$63.54M

3,522,445

$30.19M

—

Samsara BioCapital, L.P.

10% owner

$17.13M (16)

—

+$17.13M

8,497,067

$72.82M

—

RA CAPITAL MANAGEMENT, L.P. entity

Director

$15.00M (2)

—

+$15.00M

4,014,094

$34.40M

—

Jerel Davis

Director

$3.06M (1)

—

+$3.06M

1,707,719

$14.64M

—

MCCOLLUM JAMES W

Director

$740.37K (2)

—

+$740.37K

536,065

$4.59M

—

Olsson Shawn

Chief Commercial Officer

—

$261.02K (2) scheduled

−$261.02K

4,733

$40.56K

—

Schimmelpennink Evert B.

President, CEO and Secretary

$251.41K (1)

—

+$251.41K

77,289

$662.37K

—

Chevallard Daniel R.

Chief Financial Officer

$164.28K (4)

—

+$164.28K

12,886

$110.43K

—

Shah Smital

Director

$99.99K (1)

—

+$99.99K

5,882

$50.41K

—

George Jeffrey P.

Director

$49.89K (1)

—

+$49.89K

5,592

$47.92K

—

Gutry Phil

CHIEF BUSINESS OFFICER

$20.05K (1)

—

+$20.05K

299,941

$2.57M

+56.2%

Lehrer-Graiwer Joshua

PRESIDENT AND CEO

—

1,161,670

$9.96M

+49.0%

Stultz Katherine V

CHIEF OPERATING OFFICER

—

216,020

$1.85M

+3.9%

KARSEN PERRY A

Director

—

164,034

$1.41M

+5.2%

JIMENEZ JOSEPH

Director

—

161,941

$1.39M

+55.8%

Odrich Marc

Chief Medical Officer

—

99,599

$853.56K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

By person

Individual transactions

What was left out